SUBSTITUTED DIARYLAMINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

A compound represented by formula (I), and a racemate, a stereoisomer, a tautomer, an isotopic label, an N-oxide, a hydrate, a solvate, a polymorph, a metabolite, a pharmaceutically acceptable salt, a pharmaceutically acceptable ester, or a prodrug compound thereof. This class of compounds has a good LRRK2 kinase regulation and inhibition and can be used for the treatment of an LRRK2 kinase activity-associated conditions and diseases, such as proliferative diseases, protein kinase-associated diseases, lysosomal diseases, Tau diseases, and diseases caused by decreased dopamine levels, etc., and is prepared by a simple method, and has good application prospects. L'invention concerne un composé représenté par la formule (I), et un racémate, un stéréoisomère, un tautomère, une étiquette isotopique, un N-oxyde, un hydrate, un solvate, un polymorphe, un métabolite, un sel pharmaceutiquement acceptable, un ester pharmaceutiquement acceptable, ou un composé promédicament de celui-ci. Cette classe de composés a une bo